These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2396415)
1. [Results of the long-term observation and treatment of patients with arterial hypertension]. Draganov V; Orbetsov M; Pavlov V Vutr Boles; 1990; 29(1):30-5. PubMed ID: 2396415 [TBL] [Abstract][Full Text] [Related]
2. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades. Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553 [TBL] [Abstract][Full Text] [Related]
3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
4. [Hypertension management in general practice in Iceland]. Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320 [TBL] [Abstract][Full Text] [Related]
5. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546 [TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
7. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Eberhard OK; Kliem V; Offner G; Oldhafer K; Fangmann J; Pichlmay R; Koch KM; Brunkhorst R Clin Transplant; 1997 Oct; 11(5 Pt 1):415-9. PubMed ID: 9361933 [TBL] [Abstract][Full Text] [Related]
8. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
9. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
10. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus]. Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043 [TBL] [Abstract][Full Text] [Related]
11. Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. Aksnes TA; Kjeldsen SE; Rostrup M; Störset O; Hua TA; Julius S J Hum Hypertens; 2008 Aug; 22(8):520-7. PubMed ID: 18509347 [TBL] [Abstract][Full Text] [Related]
12. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905 [TBL] [Abstract][Full Text] [Related]
13. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
14. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study]. Krupicka J; Ceypová K; Kristenová P; Hauser T Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675 [TBL] [Abstract][Full Text] [Related]
15. [Quality of life in patients with essential arterial hypertension. Part II: The effect of clinical factors]. Klocek M; Kawecka-Jaszcz K Przegl Lek; 2003; 60(2):101-6. PubMed ID: 12939856 [TBL] [Abstract][Full Text] [Related]
16. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Itskovitz HD Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
18. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes. Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524 [TBL] [Abstract][Full Text] [Related]
19. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk]. Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820 [TBL] [Abstract][Full Text] [Related]
20. [Drugs and arterial stiffness in hypertensive patients]. Laurent S Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]